XCancer

Medical Experiment - Assessment of Efficacy & Safety of Local, Targeted Therapy With Neuropeptide Labelled With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) as Supplementary Therapy in Glioma (WHO G3-G4) Progression

Description:

The aim of this study is to assess the efficacy and safety of local targeted therapy with [225Ac]Ac-DOTA-SP in recurrent glioblastoma.

Sponsor:

Medical University of Warsaw

Phase:

N/A

Contacts:

Przemysław Kunert (Professor)

przemyslaw.kunert@wum.edu.pl

+48 22 599 2575

Government Study Link:

NCT06975332 - Click here to see study on

ClinicalTrials.gov

[225Ac]Ac-DOTA-SP

Isotope(s):
Target(s):
  • Substance P
Chelator: DOTA